Literature DB >> 20153295

Yap is a novel regulator of C2C12 myogenesis.

Kevin I Watt1, Robert Judson, Paul Medlow, Kenneth Reid, Tobias B Kurth, Jatin G Burniston, Aivaras Ratkevicius, Cosimo De Bari, Henning Wackerhage.   

Abstract

The expression, regulation and function of mammalian Hippo pathway members in skeletal muscle is largely unknown. The aim of this study was thus to test the hypothesis that core members of the mammalian Hippo pathway are expressed in skeletal muscle and that the transcriptional co-factor Yap, a core member of the Hippo pathway, regulates C2C12 myogenesis. We found that the major components of the mammalian Hippo pathway including Yap are all expressed in skeletal muscles, C2C12 myoblasts and myotubes. In C2C12 myoblasts, Yap Ser127 phosphorylation is low and Yap localises to nuclei. Upon differentiation, Yap Ser127 phosphorylation increases approximately 20-fold and Yap translocates from the nucleus to the cytosol. To test whether the observed increase of Yap Ser127 phosphorylation is required for differentiation we overexpressed hYAP1 S127A, a mutant that can not be phosphorylated at Ser127, in C2C12 myoblasts. We found that overexpression of hYAP S127A prevented myotube formation, whereas the overexpression of wildtype hYAP1 or empty vector had no effect. In addition, more hYAP1 S127A overexpressing cells progressed through the S phase of the cell cycle and the expression of MRFs (myogenin, Myf5), Mef2c and cell cycle regulators (p21, cyclin D1) was significantly changed when compared to wildtype hYAP1 and empty vector overexpressing cells. This data suggests that the phosphorylation of Yap at Ser127 leads to a changed expression of MRFs and cell cycle regulators and is required for C2C12 myoblasts to differentiate into myotubes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153295     DOI: 10.1016/j.bbrc.2010.02.034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  56 in total

1.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

Review 2.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

Review 3.  YAP and TAZ: a nexus for Hippo signaling and beyond.

Authors:  Carsten Gram Hansen; Toshiro Moroishi; Kun-Liang Guan
Journal:  Trends Cell Biol       Date:  2015-06-02       Impact factor: 20.808

Review 4.  Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing.

Authors:  Iwan Setiawan; Ardo Sanjaya; Ronny Lesmana; Paul M Yen; Hanna Goenawan
Journal:  J Physiol Biochem       Date:  2021-01-26       Impact factor: 4.158

Review 5.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

6.  Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.

Authors:  Justin H Hwang; Arun T Pores Fernando; Nathalie Faure; Shaida Andrabi; Guillaume Adelmant; William C Hahn; Jarrod A Marto; Brian S Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 7.  The Hippo signaling pathway in stem cell biology and cancer.

Authors:  Jung-Soon Mo; Hyun Woo Park; Kun-Liang Guan
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

8.  YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.

Authors:  Zhaohui Yang; Alexandra L Joyner
Journal:  Dev Biol       Date:  2019-07-31       Impact factor: 3.582

9.  Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.

Authors:  Zeyu Yang; Kentaro Nakagawa; Aradhan Sarkar; Junichi Maruyama; Hiroaki Iwasa; Yijun Bao; Mari Ishigami-Yuasa; Shigeru Ito; Hiroyuki Kagechika; Shoji Hata; Hiroshi Nishina; Shinya Abe; Masanobu Kitagawa; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

10.  FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling.

Authors:  Anastasia Knyazeva; Aleksandr Khudiakov; Raquel Vaz; Aleksey Muravyev; Ksenia Sukhareva; Thomas Sejersen; Anna Kostareva
Journal:  Genes (Basel)       Date:  2020-11-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.